Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Authors:
Open Access
- 11 January 2025
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 612, 217460
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82230004, 81970113)
- National Key Research and Development Program of China
- Innovative Research Group Project of the National Natural Science Foundation of China
- Capital Health Research and Development of Special Fund (2022-1-4082)
- Key Technologies Research and Development Program (2021YFC2500304)
This publication has 78 references indexed in Scilit:
- Clinical outcome of therapy‐related acute myeloid leukemia patients. Real‐life experience in a University Hospital and a Cancer Center in FranceCancer Medicine, 2023
- Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and managementAmerican Journal of Hematology, 2023
- Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemiaAmerican Journal of Hematology, 2023
- Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasmsAmerican Journal of Hematology, 2022
- Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and managementAmerican Journal of Hematology, 2021
- Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern EraJAMA Oncology, 2019
- Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantationAmerican Journal of Hematology, 2018
- Characteristics and outcome of therapy‐related myeloid neoplasms: Report from the Italian network on secondary leukemiasAmerican Journal of Hematology, 2015
- Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the Swedish Acute Leukemia RegistryAmerican Journal of Hematology, 2014
- Predictive factors for latency period and a prognostic model for survival in patients with therapy‐related acute myeloid leukemiaAmerican Journal of Hematology, 2013